Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 98 citing articles:

ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis
Dongdong Zheng, Jia Liu, Hulin Piao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 272
Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress
María Dolores Mauricio, Sol Guerra‐Ojeda, Patricia Marchio, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 166
Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
Nadezda Apostolova, Francesca Iannantuoni, Aleksandra Gruevska, et al.
Redox Biology (2020) Vol. 34, pp. 101517-101517
Open Access | Times Cited: 138
Roles of NLRP3 inflammasome in intervertebral disc degeneration
Gong Chao-yang, Cheng Peng, Haihong Zhang
Osteoarthritis and Cartilage (2021) Vol. 29, Iss. 6, pp. 793-801
Open Access | Times Cited: 118
Functionalized Metal–Organic Framework‐Modified Hydrogel That Breaks the Vicious Cycle of Inflammation and ROS for Repairing of Diabetic Bone Defects
An Lao, Jiaqing Wu, Dejian Li, et al.
Small (2023) Vol. 19, Iss. 36
Closed Access | Times Cited: 47
Loganin Attenuates High Glucose-Induced Schwann Cells Pyroptosis by Inhibiting ROS Generation and NLRP3 Inflammasome Activation
Yu‐Chi Cheng, Li‐Wen Chu, Jun‐Yih Chen, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 1948-1948
Open Access | Times Cited: 134
Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome
Milagros Rocha, Nadezda Apostolova, Rubén Díaz‐Rúa, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 10, pp. 725-741
Open Access | Times Cited: 113
ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis
Xinnong Chen, Xiao-chen Guo, Qihui Ge, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 103
Ginsenoside Rd ameliorates colitis by inducing p62-driven mitophagy-mediated NLRP3 inflammasome inactivation in mice
Chao Liu, Jianing Wang, Yan Yang, et al.
Biochemical Pharmacology (2018) Vol. 155, pp. 366-379
Closed Access | Times Cited: 99
Inhibition of GSK-3β alleviates cerebral ischemia/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy
Yueting Wang, Changchang Meng, Jinyan Zhang, et al.
International Immunopharmacology (2019) Vol. 68, pp. 234-241
Closed Access | Times Cited: 90
NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?
Na Jiang, Jinyang An, Kuan Yang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 84
Ginsenoside Rg1 prevent and treat inflammatory diseases: A review
Yan Gao, Juntong Li, Jin Wang, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106805-106805
Closed Access | Times Cited: 77
MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
Jianhang Jiao, Guanjie Zhao, Yang Wang, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 72
Mitochondria-targeted drugs for diabetic kidney disease
Akira Mima
Heliyon (2022) Vol. 8, Iss. 2, pp. e08878-e08878
Open Access | Times Cited: 52
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway
Zhaojun Wang, Xinru Li, Shi-Fan Chai, et al.
Neuropharmacology (2023) Vol. 240, pp. 109716-109716
Closed Access | Times Cited: 39
Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease
Aikaterini Andreadi, Saverio Muscoli, Rojin Tajmir, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1646-1646
Open Access | Times Cited: 27
Sirtuin4 alleviates severe acute pancreatitis by regulating HIF-1α/HO-1 mediated ferroptosis
Yanna Liu, Huning Cui, Chaopeng Mei, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 22
<p>Emodin Protects Against Acute Pancreatitis-Associated Lung Injury by Inhibiting NLPR3 Inflammasome Activation via Nrf2/HO-1 Signaling</p>
Zhenming Gao, Jidong Sui, Rong Fan, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 1971-1982
Open Access | Times Cited: 66
Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice
Pan Pan, Zhang Qi, Weiyong Liu, et al.
Journal of Virology (2019) Vol. 93, Iss. 21
Open Access | Times Cited: 58
CY-09 attenuates the progression of osteoarthritis via inhibiting NLRP3 inflammasome-mediated pyroptosis
Yao Zhang, Zihao Lin, Deheng Chen, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 553, pp. 119-125
Closed Access | Times Cited: 43
Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment
Haiyang Yu, Tong Sun, He Xin, et al.
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1591-1591
Open Access | Times Cited: 30
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
Ye Tao, Weiyan Tao, Xiaoyi Chen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 1-13
Closed Access | Times Cited: 17
NLRP3 inflammasome-mediated premature immunosenescence drives diabetic vascular aging dependent on the induction of perivascular adipose tissue dysfunction
Guang-Jie Tai, Yan-Jie Ma, Jun-Lin Feng, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 7
NEK7: a potential therapy target for NLRP3-related diseases
Ganglei Liu, Xueliang Chen, Qianqian Wang, et al.
BioScience Trends (2020) Vol. 14, Iss. 2, pp. 74-82
Open Access | Times Cited: 49
Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview
Min Wu, Xiaoya Li, Songzi Wang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 128, pp. 110308-110308
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top